IMDX
IMDX
NASDAQ · Biotechnology

Insight Molecular Diagnostic

Stocks Under $10 Biotech Stocks Healthcare Stocks
$7.32
+0.63 (+9.42%)
As of Feb 8, 2:05 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +137.8% upside
Low Target $14.05
Average Target $17.41
High Target $26.42
Current Price $7.32
Current
$7.32
Target
$17.41
$14.05 $17.41 avg $26.42
Scenario Analysis
Bear Case
$14.05
91.9%
Low target
Base Case
$17.41
+137.8%
Avg target
Bull Case
$26.42
+260.9%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$15.94
-54.1% from high
52-Week Low
$11.01
+-33.5% from low
Target vs 52W High
$17.41
+9.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%